Xenograft Models
Advance your research with proprietary and validated xenograft models to test drug efficacy, optimize leads, and drive confident preclinical decisions.
In Vivo Pharmacology
Explore our comprehensive portfolio of in vivo pharmacology offerings for tailored solutions backed by expert support. Accelerate all phases of your preclinical oncology research, and let’s discover together.
Hollow Fiber Model
Reduce timelines and costs with the Hollow Fiber Model, a streamlined in vivo pharmacology tool that delivers dependable compound efficacy data in as little as two weeks.
Kinase Activity Models
Investigate kinase-targeted therapies with in vivo models that assess compound efficacy, explore resistance mechanisms, and deliver actionable insights.
Immuno-Oncology Tumor Models
Unlock critical insights into immune modulation and therapy outcomes with precision-driven in vivo models for evaluating efficacy and immune response.
PK & PD Studies
Make informed decisions with in vivo PK/PD studies that deliver critical insights into dosing, drug distribution, and target engagement to optimize preclinical outcomes.
Maximum Tolerated Dose
Identify the optimal dose for safety and efficacy with MTD studies, providing precise, data-driven insights to guide your preclinical drug development.
Delivering Reliable In Vivo Insights for 20+ Years
100+
Validated xenograft models available
2 weeks
For actionable drug efficacy data
6000+
Ft2 of AAALAC- and ISO9001-accredited facilities
2000+
Clients supported worldwide
Expert support from start to finish
Partner with Reaction Biology for GV-SOLAS and ISO9001-certified in vivo pharmacology services. Your dedicated project manager ensures seamless collaboration, guiding you from study design through final reporting to deliver reproducible insights that accelerate your research goals.
